Ara
Toplam kayıt 2, listelenen: 1-2
Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment
(Akad Doktorlar Yayinevi, 2020)
The most important factor in the transmission of the COVID-19 is asymptomatic carriers. We've tested all oncology patients , that receive anti-cancer therapy, for COVID-19. We aimed to determine the rate of asymptomatic ...
What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?
(Aves, 2022)
Objective: Recommendations for the treatment of cytokine release syndrome/macrophage activation syndrome (MAS) associated with coronavirus disease-2019 (COVID-19) are still of poor quality. IL-6 is an important therapeutic ...